Traduction de «control eye disease progression » (Anglais → Français) :

control eye disease progression | control progession of eye diseases | determine eye disease progression | determine eye disease progressions

A rare acquired eye disease with characteristics of progressive visual loss due to bilateral juxta foveolar capillary occlusions, capillary telangiectasia and minimal exudation. It is associated with systemic or cerebral vascular occlusive disease.

Disease with characteristics of early-onset of cerebellar signs with eye movement abnormalities and a very slow disease progression.Three families have been reported to date. Clinical manifestations include cerebellar signs (ataxia, dysarthria, and i

Definition: The schizophrenic disorders are characterized in general by fundamental and characteristic distortions of thinking and perception, and affects that are inappropriate or blunted. Clear consciousness and intellectual capacity are usually maintained although certain cognitive deficits may evolve in the course of time. The most important psychopathological phenomena include thought echo; thought insertion or withdrawal; thought broadcasting; delusional perception and delusions of control; influence or passivity; hallucinatory voices commenting or discussing the patient in the third person; thought disorders and negative sym ...[+++]ptoms. The course of schizophrenic disorders can be either continuous, or episodic with progressive or stable deficit, or there can be one or more episodes with complete or incomplete remission. The diagnosis of schizophrenia should not be made in the presence of extensive depressive or manic symptoms unless it is clear that schizophrenic symptoms antedate the affective disturbance. Nor should schizophrenia be diagnosed in the presence of overt brain disease or during states of drug intoxication or withdrawal. Similar disorders developing in the presence of epilepsy or other brain disease should be classified under F06.2, and those induced by psychoactive substances under F10-F19 with common fourth character .5.

Decision 2119/98/EC establishes that Member States have to provide a series of information of relevance to the surveillance and control of communicable diseases, including information on their occurrence, the progression of the epidemic situation, as well as on intended or adopted measures for the control or prevention of these diseases.

Ensure that the EU international drug response is evidence-based and includes a monitoring process on the situation and progress involving different information tools from the Commission, EEAS, including the EU Delegations, Member States, EMCDDA, Europol, Eurojust and the European Centre for Disease Prevention and Control in close cooperation with UNODC.

– having regard to the 2010 report of the European Centre for Disease Prevention and Control (ECDPC) entitled ‘Progress on implementing the Dublin Declaration on the Partnership to Fight HIV/AIDS in Europe and Central Asia’,

The Political Declaration of the High-level Meeting on the Prevention and Control of Non-communicable Diseases approved by the United Nations General Assembly Resolution 66/2 of 19 September 2011 ; and that according to its paragraph 65, a report on progress achieved will be presented at the 69th UNGA in September 2014.